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Abstract 
Purpose:  To compare the efficacy of computer-aided dosing using Coagclinic (a web-based 
software) with physician dosing in patients receiving warfarin for various cardiac indications.  
Met hods:  In order to calculate the effectiveness of physician managed anticoagulation dosing, we 
calculated the “percentage of time international normalized ratio, INR, was in the therapeutic range" 
(TTR) for a random sample of 70 patients in the center. For each patient, 4 INR values were taken at 
4 consecutive visits, before and after the installation of Coagclinic. Data on the doses given by 
physicians were collected at each visit and c o m p ar ed  them with the pharmacy-based computer 
aided dosing system data.   
Results:  After performing paired samples t-test of doses based on the physician group with those 
based on the computer system (mean -1.5654 ± 2.09 ), a statistically significant difference was found (p < 
0.015).   Furthermore, the patients kept at TTR by physicians amounted to 26 % compared to 70 % by 
the software.  
Conclusion: The difference between TTR managed by physicians and those managed using 
CoagClinic™ software is statistically significant. It appears that the software improves the effectiveness of 
warfarin dosing in patients.  
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Warfarin is a vitamin K antagonist widely 
used worldwide for many clinical disorders 
including atrial fibrillation (AF) [1]. Many 
patients with AF and other thrombotic 
disorders have not been able to receive 
this treatment or have only been treated 
for a restricted period due to their large 
numbers; secondly, resources for 
anticoagulant administration are limited. 
The efficacy and safety of vitamin K 
antagonists (VKA) are related to the actual 
level of  anticoagulation given as the 
international normalized ratio (INR). It is 
often difficult to maintain an optimal INR 
over time [2]. In many countries, health 
care facilities have turned to a range of 
commercial and non-commercial 
computer-assisted dosage programs 
(CDSSs) to facilitate anticoagulation 
dosing by nurses, pharmacists and 
laboratory technologists.   
  
Computer programs that predict dosage 
adjustments of  oral anticoagulants and the 
time interval to the next test have been 
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shown to  improve  the  quality  and  
efficiency  of  oral  anticoagulation  
therapy  OAT  and  are  being increasingly 
used in practice[10-15] . CoagClinic™ is a 
well known web based software that offers 
a web-based, customizable approach to 
the management and documentation of 
anticoagulation therapy. The main benefits 
include tracking use of approved 
protocols, patient-specific support for 
warfarin and low molecular weight heparin 
dosing and documentation of patient 
education for follow up monitoring, 
adherence  tracking and counseling 
regarding nutrition as well as compliance 
and drug-drug interactions (DDI's)[3]. 
 
Though there are many studies showing 
superiority of CDSSs in many aspects of 
medical care, not many studies have been 
undertaken to demonstrate their effect on 
patient outcome [11-17]. CDSSs are in 
use in many countries but not in Saudi 
Arabia  Lastly, the efficacy of OAT 
depends not only on defining the target 
INR but also maximizing the length of  time 
the patient’s INR is maintained within the 
designated therapeutic range TTR[4]. 
Therapeutic INR range (TTR) is a way of 
summarizing INR control over time. TTR 
has been studied mostly in the setting of 
clinical trials where it is used to evaluate 
the effectiveness of warfarin therapy. 
However, TTR has been underutilized as a 
quality measure. Infact, there has been a 
general lack of quality evaluation and 
monitoring in oral anticoagulation clinics. 
There is much evidence that better 
anticoagulation control (i.e., higher TTR) 
can protect patients from severe or even 
fatal adverse events [5].  
Our study aims to analyze the application 
of  computer software-aided 
anticoagulation dosing in Saudi Arabia 
and its effect on the time that blood levels of 





A prospective interventional clinical study 
was conducted to investigate the impact of 
computer-assisted Warfarin dosing 
compared to  routine clinical dosing by 
physicians. The ethical approval for the 
study was obtained from the ethical 
committee in King Fahad Specialist 
Hospital. A convenient sample of patients 
were recruited for this study. Consenting 
patients were assessed for compliance to 
therapy  based on the Moriski scale and 
missing day’s role [6]. The study 
population consisted of patients on 
anticoagulant therapy in the form warfarin 
and were being managed in the 
anticoagulation clinic of Prince Sultan 
Cardiac Center (PSCC) in Al-Qassim, 
Kingdom of Saudi Arabia.  
 
Patients whose compliance was > 80 % 
were informed about the study for possible 
recruitment. Upon understanding and 
accepting the policy and procedures to be 
used, they were asked to sign the 
informed consent form. Care was taken to 
ensure patient confidentiality.   
 
INCLUSION CRITERIA  
 
Patients with various cardiac indications 
were enrolled if they fulfilled the following 
criteria: 
1. Current stable therapy on warfarin  
2. Treatment compliance of more than 80 
% [6] . 
3. Understanding of  the procedure of  the 
research and could follow simple 
instructions 
4. Willingness to sign the written informed 
consent form 
 
EXCLUSION CRITERIA  
1. Patients aged < 18 years. 
2. Patients newly started on warfarin and not yet 
stabilised. 
3. Patients with bleeding disorders such as 
hemophilia 
 
Comparison between the dosing of 
physician and doses given by computer 
software was made to evaluate the 
differences in TTR and dosing, if any. The 
computer software used was Coagclinic® a  
web based system in the United States, for 
management of anticoagulation dosing 
including warfarin, heparin, low molecular 
weight heparins (LMWHs) and the new oral 
anticoagulants.  
 
For the purpose of completing this study, 
appopriate data extraction form was used 
to collect related data to be analyzed later. 
The prospective users’ perceptions and 
attitudes toward the implementation of  the 
new software were recorded and the notes 
taken will  be useful in developing 
recommendations of  the usage. The main 
source of data collected was the INR 
values recorded at various visits, patients’ 
f iles in the clinic, and the interviews with 
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patients’ were considered as a source of 
some data related to patients’ history. After 
obtaining their consent, 110 patients on 
warfarin were recruited. The INR was 
measured using point of  care analyzer 
Coagucheck (Roche) and for any INR value 
> 4, additional testing was carried out using 
i-Stat analyzer (Abbott). This method was 
evaluated in our center to be sensitive, as 
Coagucheck was found not to be not very 
accurate for high INR readings in another 





The data were all saved in CoagClinic and 
then exported to Microsoft Excel®. 
Confounding variables such as sex, 
compliance, different indications for 
anticoagulation, were taken into account 
while carrying out the statistical analysis 
of  the collected data. The data were then 
were exported to Minitab® to be used for 
statistical analysis and testing the 
research hypothesis. The power of the 
hypothesis was used to detect the 
expected sample size of the study, as the 
standardized difference was determined. 
By using the standardized difference, we 
would have a high chance of detecting a 
clinically important difference if it exists. 
The power and level of significance were 




Of the 110 patients recruited for  the study, 
70 patients completed the study and for 
each patient, four INR values were 
recorded from 4 consecutive visits before 
and after implementation of the software. 
Since our unit of analysis was the INR, we 
had about 280 samples in each arm. Of 
these 70 patients completing the study, 
42.8 % was male and 56.3 % female.   
 
Descriptive data of sex, indications and 
TTR 
 
Looking at the different indications for 
anticoagulation, there were 57.2% subjects 
with atrial f ibrillation (AF), 20% with mitral 
valve replacement (MVR), 18.5%, with 
aortic valve replacement (AVR), and 4.3% 
with dual valve replacement (DVR) (Table 
1). 
 
As shown in Table 2, there is a significant 
difference between the dosing of the 
physicians at the clinic and the doses 
generated by the computer software since 
the calculated t-value is higher than the 
indexed one (p  0.05).  
 
Impact of CoagClinic, gender and 
indications on TTR and dosing 
 
After controlling all the confounders, 
including demographics and prescribers, 
we found that the percentage of patients 
kept at the TTR by physicians was 26 %, 
as 71 % for the software within six month 
of  the commencement of its application A 
significant difference (p = 0.015) was found 
between physicians' dosing and the dosing 
generated by the computer software (table 
3). Furthermore, there was no significant 
association between different indications 
for anticoagulation therapy and the 
calculated TTR (p = 0.61). Likewise, there 
was no significant association between 
gender and the calculated TTR (p=0.59).   
Table 1: Patient demographics and indications for anticoagulation  
 
Total no of patients  Male Female 
70 (30)42.9 % (40)57.1% 
Indication for anticoagulation*  
Atrial fibrillation 
No (%) 
Mitral valve replacement Aortic valve 
replacement 
Dual valve replacement 
40(57.2%) 14(20%) 13(18.5%) 3(4.3%) 
*Some patients had more than one indication  
Table 2: Paired samples t-test data 
 
Pairing Mean sd t-test P value 
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Table 3: Comparison of TTR of patients on physician-dosed with computer-managed 
anticoagulation 
 
% of TTR in therapeutic range  
Physician-dosed Computer-managed P-value 




In order to improve the demonstrated lack 
of success of medical and other staff in 
achieving INR target  ranges,  computer 
assistance  of  anticoagulant  dosage  has  
been  advocated  which  may improve 
dose management and "time in range".   
As a result, standards of dosage of the 
best centers (e.g.>70% of time in target 
INR range) are being made available by 
computer programs [7].  A CDSS is any 
software designed to directly aid in clinical 
decision making in which characteristics of 
individual patients are matched to a 
computerized knowledge base for the 
purpose of generating patient-specific 
assessments or recommendations that are 
then presented to clinicians for 
consideration. Advantages of  Computer 
aided dosing include  better levels of 
control with less dose changes ,this 
minimizes risk as every time a patient 
changes dose, there is a possibility for 
errors and the wrong dose is taken. 
Medical staff shows natural increased 
caution in dosing patients at a higher INR 
range, this caution often means that 
patients run on the lower end of ranges 
and below. Computer assisted dosing also 
allows Standardization of Care across all 
healthcare professional’s managing 
patients within an organization. 
Standardization is the first step to 
improving the whole Quality of Care.  It 
also  allows institutions to set their own 
dosing rules, if required. 
 
However, the safety and effectiveness of 
such computer assistance requires clinical 
validation for each and every program. 
Computerized Decision Support Systems 
(CDSSs) can enhance clinical 
performance for drug dosing, preventive 
care, and other aspects of medical care. 
Many clinical situations have been 
investigated to verify the utility of CDSS, 
few have demonstrated stable effects [8]. 
One area where success has been 
reported is the field of  oral anticoagulation 
management. CDSS system has been 
demonstrated to improve treatment quality 
in comparison to the manual method. The 
constant increase of patient numbers and 
their pressure on thrombosis centers have 
led to the development of  alternative 
models for delivery of oral anticoagulation 
therapy [9]. Primary care, General 
Practitioner, Patient self testing and self 
management and the use of  CDSS has 
been central to the  decentralization  
process  and  may  be  useful  in  
maintaining  the  efficacy  and  quality  of 
anticoagulant control. In the future 
scenario of oral anticoagulant 
management CDSS will have a pivotal 
part, General practitioners with the aid of 
CDSS are able to deliver OAT as well as 
expert physicians of Thrombosis Centers 
in terms of  time spent by patient in 
therapeutic range (TTR) [10]. 
 
According to Van Leeuwen, the improved 
control of anticoagulant dosage (ICAD) 
algorithm is based on a model that 
comprises the pharmacokinetics and 
pharmacodynamics of the oral anticoa-
gulant drug, the pharmacokinetics of the 
prothrombin complex, and the relationship 
between the activ ity of  the prothrombin 
complex and the measured INR[11].  
Ageno, et al, 1998 shows that  the  use  of 
computer algorithms to assist physicians 
with their dosing decisions has been 
shown to lead to equal or improved quality 
of  control of oral anticoagulant treatment 
as compared to unassisted dosing [12].  
 
The DAWN AC (anticoagulation) is one of 
the most widely used computer-dosage 
programs. Evidence of its value and that 
of  other computer programs has been 
based previously only on laboratory 
evidence of "time in target INR range" 
(TTR).The DAWN AC computer dosage 
program proved as safe clinically as 
manual dosage by experienced medical 
staff [13].  SintromacWeb  telecontrol  is  a  
new  model  for  management  of   anticoa-
gulated patients. It is an internet based 
tool. It was highly accepted and can be 
used by all patients regardless of their 
socio demographic characteristics [14]. 
Moreover, Fitzmaurice, et al. 
demonstrated that the use of 
computerized decision support systems 
(CDSSs) may overcome lack of 
Almeman & Rasool 
Trop J Pharm Res, December 2013;12 (6): 
 
1069 
experience, having demonstrated 
significant improvement in dosing and 
recall  decisions based on the international 
normalized ratio (INR) result when used in 
primary care and hospital settings [12]. A 
CDSS can reduce the reliance on 
specialist delivery of anticoagulation care, 
enabling other health care professionals to 
manage clinics. 
  
Similar to other studies, the statistical 
analysis didn't show any significant 
differences in the groups that could be 
referred to demographic variables, 
prescribers, or indications. Accordingly, 
we can generalize the usage of this 
software for the purpose of the dosing of 
anticoagulation to improve the 
effectiveness of  the clinic regardless of 
such confounders. 
 
On the top of this, the optimization 
process has been conducted fairly in the 
presence of such high level of non-
compliance of 20 %. Thus, the software 
might be also effective to help this cohort 
of  patients to optimize their INR. However, 
the study was not designed to investigate 
the effect of sotware on compliance of 
patients, and an affirmative conclusion is 
required with another study.  
 
The results obtained by the statistical 
analysis and the observation of the 
behavior of prospective users in our study 
show that the use of computer system in 
the dosing of anticoagulation therapy has 
many implications. The use of computer 
software in the dosing of anticoagulation 
therapy is to improve the process of 
calculating the doses and monitoring the 
therapeutic regimen as well. The results 
showed that there is significant difference 
between the doses given by physicians 
and the doses given by the computer 
software according to the latest guideline 
of  dosing released by medical institutions 
that are updated almost every day. 
Seemingly, differences in dosing have 
resulted in a better response and longer 
time within the designated INR range  
  
In comparison to DAWN AC, and other 
software, CoagClinic has the ACCP 
(American college of chest physicians) 
guidelines implemented in it, provides the 
users with many alerts according to the 
best published and mostly updated 
guidelines. In addition to dosing, the user 
will  be alerted on any potential drug-drug 
interactions and the expected INR 
changes, allowing the user to work 
proactively and keep the patient in the 
TTR as long as possible. Further, it is 
supplemented with a flow chart on what 
to do in case of prolonged INRs, and the 
best clinical recommendations in such 
scenarios. Several other features have 
not been utilized by us including, SMS 
services, heparin dosing, LMWH dosing, 
and dealing with the new oral 
anticoagulants. One of  the main factors 
to consider, also, is the price. It is 
annually-renewed and dependant on 
number of patients. In our situation, the 
cost is $ 10,000 with a limit of 3000 
patients. Several studies have shown that 
the CDSSs are cost-effective and the 
cost is justified. Our case has shown a 
clear clinical significance, and optimal 
outcomes.  
 
The application process of  computerized 
dosing system of anticoagulation therapy 
was passed through diff iculties while 
implementing the process in many 
aspects. The computer software needs on-
the-job (OJT) training programs for the 
benefit of users. The users of software 
faced problems such as logging in the 
software interface and many other 
problems related to the internet 
connection since the software is only 
accessible online. In our situation, the 
internet speed is acceptable and we had 
no disconnections during the whole period 
of  the study. However, the most 
problematic issue that we had is the newly 
implemented e-prescription model in the 
hospital, leading to duplication, as we 
have to deal with two programs at the 
same time. This has restricted the optimal 




The use of CoagClinic improves the 
effectiveness of  the anticoagulation dosing 
process and results in better TTR.  
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